5 Best Long-Term Dividend Stocks to Invest In According to Billionaires

4. The Cigna Group (NYSE:CI)

Number of Billionaire Holders: 29

On May 26, Barclays turned more cautious on The Cigna Group (NYSE:CI), downgrading the stock to Equal Weight from Overweight. It also trimmed its price target on the stock to $304 from $310.The firm said Cigna has less room for earnings upside than some of its peers because of its limited exposure to government insurance programs. In addition, Barclays pointed to uncertainty tied to the company’s pharmacy benefit manager transition and questions around how quickly investment spending may ease. The analyst also sees a less attractive risk-reward setup ahead of Cigna’s investor day in September. Concerns around commercial membership losses and the possibility of AI-driven job cuts were among the factors cited in the research note.

A few days earlier, on May 22, UBS took a more positive view. The firm raised its price recommendation on Cigna to $400 from $375. It reiterated a Buy rating on the stock. According to UBS, managed care companies broadly lifted their guidance after reporting stronger-than-expected first-quarter results. Performance benefited from favorable respiratory trends and typical seasonal cost patterns. The firm added that higher Medicare Advantage rates, steadier enrollment in ACA exchanges, and modestly better Medicaid results have increased confidence in a recovery in margins. At the same time, insurers continue to face pressure from specialty drugs, GLP-1 treatments, and behavioral health costs.

The Cigna Group (NYSE:CI) is a global health company with two operating segments: Evernorth Health Services and Cigna Healthcare.